Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study

BACKGROUND: In patients with suspected heparin-induced thrombocytopenia (HIT) who need renal replacement therapy, a nonheparin anticoagulant has to be chosen to prevent thrombosis in the extracorporeal circuit. Danaparoid, a low-molecular-weight heparinoid consisting of heparan sulphate, dermatan su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: de Pont, Anne-Cornélie JM, Hofstra, Jorrit-Jan H, Pik, Derk R, Meijers, Joost CM, Schultz, Marcus J
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2007
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2556745/
https://ncbi.nlm.nih.gov/pubmed/17854496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc6119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars